SOLVED1329

A drug salesperson claims their screening test for disease “Z” adds 3 additional months to a patient’s life. Before you invest money into the screening test you review the biomedical literature concerning the new screening test. After review of the literature, you determine that 85% of patients die within 5 years of being diagnosed with disease “Z” , irrespective of whether or not they were first diagnosed by the new screening test. You also note that disease “Z” actually has an average preclinical phase of 9 months. Which of the following is most likely true? A. You should have the new screening test completed during your yearly check-up because it will add 3 additional months to your life if you are diagnosed with disease “Z” B. The new screening test clearly adds 3 months of life to patients diagnosed with disease “Z”; however, you must evaluate cost-effectiveness before you invest in this product C. The drug salesperson’s claim that the screening test adds 3 additional months of life is likely due to “Lead Time Bias”
SCIENCE
HEALTH SCIENCE
NURSING

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."